Papers - HATAKEYAMA SHINGO
-
Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study.
Kazuhisa Hagiwara, Takuya Koie, Hiromichi Iwamura, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BioMed research international 2016 4975851 - 4975851 2016
-
Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.
Tendo Sato, Shingo Hatakeyama, Teppei Okamoto, Hayato Yamamoto, Shogo Hosogoe, Yuki Tobisawa, Tohru Yoneyama, Eiji Hashiba, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuyoshi Hirota, Chikara Ohyama
PloS one 11 ( 5 ) e0153961 - e0153961 2016
-
Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].
Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
PloS one 11 ( 2 ) e0149544 2016
-
The potential role of blood group antigen-targeting peptide in ABO-incompatible in renal transplantation
69 ( 13 ) 1093 - 1100 2015.12
-
I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.
Jotaro Mikami, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda
Cancer science 2015.12
-
Intracorporeal urinary diversion
69 ( 11 ) 924 - 928 2015.10
-
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori
International urology and nephrology 47 ( 9 ) 1509 - 1514 2015.9
-
Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.
Takuya Koie, Chikara Ohyama, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Shogo Hosogoe, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota
International journal of clinical oncology 2015.7
-
Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.
Takahiro Yoneyama, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
International journal of clinical oncology 2015.5
-
Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.
Med Oncol. 2015.1
-
Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.
Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori
BMC urology 15 32 - 32 2015
-
Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
Hiromichi Iwamura, Takuya Koie, Osamu Soma, Teppei Matsumoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BMC urology 15 120 - 120 2015
-
Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa
PloS one 10 ( 9 ) e0138520 - e0138520 2015
-
Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy.
Shogo Hosogoe, Osamu Soma, Teppei Matsumoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Masahiko Aoki
Case reports in urology 2015 839738 - 839738 2015
-
Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.
Yusuke Ishibashi, Yuki Tobisawa, Shingo Hatakeyama, Tetsu Ohashi, Masakazu Tanaka, Shintaro Narita, Takuya Koie, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama, Tohru Yoneyama
The Prostate 74 ( 15 ) 1521 - 1529 2014.11
-
Reassessment of Prognostic Heterogeneity of pT3 Renal Pelvic Urothelial Carcinoma: Analysis in Terms of Proposed pT3 Subclassification Systems
Jinsung Park, Tomonori Habuchi, Youichi Arai, Chikara Ohyama, Takamitsu Inoue, Shingo Hatakeyama, Seong Soo Jeon, Ghee Young Kwon, Cheol Kwak, Kyung Chul Moon, Choung-Soo Kim, Hanjong Ahn
Journal of Urology 192 ( 4 ) 1064 - 1071 2014.10
-
A patient experienced acute dyspnea and chest pain at first postoperative walking after a open or laparoscopic surgery
68 ( 9 ) 685 - 687 2014.8
-
Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Masato Kitayam, Kazuyoshi Hirota
Urologic oncology 32 ( 6 ) 820 - 825 2014.8
-
Tubulocystic renal cell carcinoma in the left kidney: a case report.
Yusuke Ishibashi, Takuya Koie, Naoki Fujita, Tendo Satoh, Jotaro Mikami, Shingo Hatakeyama, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama
Journal of medical case reports 8 ( 1 ) 265 - 265 2014.7
-
Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer.
Tohru Yoneyama, Chikara Ohyama, Shingo Hatakeyama, Shintaro Narita, Tomonori Habuchi, Takuya Koie, Kazuyuki Mori, Kazuya I P J Hidari, Maho Yamaguchi, Takashi Suzuki, Yuki Tobisawa
Biochemical and biophysical research communications 448 ( 4 ) 390 - 396 2014.6